Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
2016
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
The 2017 hormone therapy position statement of The North American Menopause Society
2017
The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections
2012
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation
2014
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Osteoporosis
2019 Standout
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
2013
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
1997
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The role of oxidized phospholipids in atherosclerosis
2008
Chinese Guidelines for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2010
2012
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
2012
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
2008
The Serotonin Syndrome
2005 Standout
Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects
2012
Comparison of Duloxetine, Escitalopram, and Sertraline Effects on Cytochrome P450 2D6 Function in Healthy Volunteers
2007
Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia
2012
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Thyroid Hormone Analogues for the Treatment of Metabolic Disorders: New Potential for Unmet Clinical Needs?
2012
Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis
2010
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Clinician-Patient Risk Discussion for Atherosclerotic Cardiovascular Disease Prevention
2015
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
2009
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
2004
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
2004
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Diabetic neuropathy
2019
Medication Adherence: WHO Cares?
2011 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
2009
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Management of growth hormone deficiency in adults
2007
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk
2014
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
2014
Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
2012
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
2014
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
Mineralocorticoid Receptor and Cardiovascular Disease
2018
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Michael Messig being referenced
Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis
2008
Remission Status After Long-Term Sertraline Treatment of Pediatric Obsessive-Compulsive Disorder
2003
Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume
2008
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene
2014
Pharmacokinetics and Pharmacodynamics of Extended‐Release Glipizide GITS Compared with Immediate‐Release Glipizide in Patients with Type II Diabetes Mellitus
2002
Effect of Change in Body Weight on Incident Diabetes Mellitus in Patients With Stable Coronary Artery Disease Treated With Atorvastatin (from the Treating to New Targets Study)
2014
Long-Term Sertraline Treatment of Children and Adolescents With Obsessive-Compulsive Disorder
2001
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
2012
Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
2013
A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
2012
Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind, Randomized Two-Year Trial
2005
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
2013
Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women
2008
Pharmacokinetics of Desipramine Coadministered With Sertraline or Fluoxetine
1994
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
2010
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
2009
Evaluation of Interaction Between Fluconazole and an Oral Contraceptive in Healthy Women
2001
Lipid Treatment Assessment Project 2
2009
Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial
2014
Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial
2009